Gerresheimer AG

XETRA GXI.DE

Gerresheimer AG Capital Expenditure for the year ending November 30, 2023: USD -357.07 M

Gerresheimer AG Capital Expenditure is USD -357.07 M for the year ending November 30, 2023, a -44.14% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).
  • Gerresheimer AG Capital Expenditure for the year ending November 30, 2022 was USD -247.73 M, a -7.31% change year over year.
  • Gerresheimer AG Capital Expenditure for the year ending November 30, 2021 was USD -230.87 M, a -11.88% change year over year.
  • Gerresheimer AG Capital Expenditure for the year ending November 30, 2020 was USD -206.36 M, a -13.85% change year over year.
  • Gerresheimer AG Capital Expenditure for the year ending November 30, 2019 was USD -181.26 M, a -39.79% change year over year.
Key data
Date Capital Expenditure Free Cash Flow Depreciation And Amortization Deferred Income Tax
Market news
Loading...
XETRA: GXI.DE

Gerresheimer AG

CEO Mr. Dietmar Siemssen
IPO Date June 11, 2007
Location Germany
Headquarters Klaus-Bungert-Strasse 4
Employees 12,012
Sector Materials
Industries
Description

Gerresheimer AG, together with its subsidiaries, manufactures and sells packaging products, and drug delivery-devices and solutions worldwide. It operates through Plastics & Devices, Primary Packaging Glass, and Advanced Technologies divisions. The Plastics & Devices division offers drug delivery systems, including inhalers, insulin pen systems, prefillable syringes, and diagnostic systems for the pharma, biotech, diagnostics, and medical technology industries; containers and closures, PET bottles, eye droppers, nasal sprays, nebulizers, applicators, and accessories for solid, liquid, and ophthalmic applications; and bottles and containers for nutritional supplements. The Primary Packaging Glass division offers glass primary packaging for pharma and cosmetics industries, such as infusion, dropper, and syrup bottles; injection vials, ampoules, and cartridges; miniature bottles and glass containers for liquid food, spices, and spirits; and packaging solutions for fragrances, deodorants, skin care, and wellness products, as well as beauty and pharmaceutical products. The Advanced Technologies division develops smart drug delivery systems, such as micro pumps, which are used to self-administer medication for Parkinson's disease or heart failure to pharmaceutical and biotech customers. The company was founded in 1864 and is headquartered in Düsseldorf, Germany.

Similar companies

G1A.DE

GEA Group Aktiengesellschaft

USD 49.86

0.81%

SY1.DE

Symrise AG

USD 99.35

-2.63%

DUE.DE

Dürr Aktiengesellschaft

USD 22.38

0.98%

BNR.DE

Brenntag SE

USD 55.86

-1.25%

KRN.DE

Krones AG

USD 124.29

0.44%

StockViz Staff

January 15, 2025

Any question? Send us an email